Assenagon Asset Management S.A.
Position in INDV — Indivior Pharmaceuticals, Inc.
CIK 1546007
SENNINGERBERG, N4
Position in INDV
as of Jun 30, 2026
· filed Aug 21, 2026
Position Value
$63,224,275
New position
Shares Held
1,540,928
first reported quarter
Ownership
1.31%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#20
of 334 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Assenagon Asset Management S.A. holds $514,912,865 across 20 Drug Manufacturers - Specialty & Generic names. INDV ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,056,017 | $103,537,855 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
714,980 | $79,319,881 | |
| 3 | VTRS |
Viatris Inc
|
4,989,006 | $79,225,415 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
This page
|
1,540,928 | $63,224,275 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
84,538 | $45,805,224 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
2,445,549 | $42,332,453 | |
| 7 | NBIX |
Neurocrine Biosciences Inc
|
222,606 | $37,518,015 | |
| 8 | ZTS |
Zoetis Inc.
|
389,335 | $27,977,613 |
All Filings in INDV
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $63,224,275 | 1,540,928 | Shares | Sole | 2026-08-21 | |
| No filing history on record for this holder in this stock. | ||||||